SimBioSys

Chicago, IL · Founded 2017 · Privately Held (backing)

Developer of a medical platform intended to deploy computational oncology to transform decision-making and patient experience in cancer care. SimBioSys is based in Chicago, IL and was founded in 2017. Its last reported valuation was $39 million in Jul 2021. It has raised $21.1 million across 2 recorded rounds; the latest was a $5.2 million early-stage round in Dec 2024.

Last reported valuation
$39.0M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
Early Stage VC
Dec 2024

Who backs SimBioSys?

11 investors
InvestorType
Mayo ClinicOther
Fox VenturesOther
Genoa VenturesVenture capital
AV8 Ventures—
Calculus Venture Capital—
Kleinmuntz Associates—
National Cancer Institute—
National Cancer Institute I-Corps—
Northpond Ventures—
St Joseph Heritage Medical Group—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

SimBioSys investors

11 investors are on record for SimBioSys, including Mayo Clinic, Fox Ventures, Genoa Ventures and AV8 Ventures. The early-stage round in Dec 2024 drew 13 investors.

Free account
More of SimBioSys with a free account
  • ·The complete investor list: 11 names
  • ·Watch SimBioSys: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like SimBioSys. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View